(Q40497134)

English

Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 September 2017

Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study (English)

1 reference

Europe PubMed Central

21 September 2017

feasibility study

1 reference

based on heuristic

inferred from title

invasive fungal infections

1 reference

based on heuristic

inferred from title

1

object named as

Johan Maertens

1 reference

Europe PubMed Central

21 September 2017

3

object named as

Gregor Verhoef

1 reference

Europe PubMed Central

21 September 2017

5

object named as

Katrien Lagrou

1 reference

Europe PubMed Central

21 September 2017

author name string

Koen Theunissen

2

1 reference

Europe PubMed Central

21 September 2017

Johnny Verschakelen

4

1 reference

Europe PubMed Central

21 September 2017

Eric Verbeken

6

1 reference

Europe PubMed Central

21 September 2017

Alexander Wilmer

7

1 reference

Europe PubMed Central

21 September 2017

Jan Verhaegen

8

1 reference

Europe PubMed Central

21 September 2017

Marc Boogaerts

9

1 reference

Europe PubMed Central

21 September 2017

Johan Van Eldere

10

1 reference

Europe PubMed Central

21 September 2017

language of work or name

0 references

publication date

29 September 2005

1 reference

Europe PubMed Central

21 September 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

Clinical Infectious Diseases

1 reference

Europe PubMed Central

21 September 2017

41

1 reference

Europe PubMed Central

21 September 2017

9

1 reference

Europe PubMed Central

21 September 2017

1242-1250

1 reference

Europe PubMed Central

21 September 2017

Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.

1 reference

https://api.crossref.org/works/10.1086%2F496927

21 January 2018

Fungal infections in patients with neutropenia: challenges in prophylaxis and treatment

1 reference

https://api.crossref.org/works/10.1086%2F496927

21 January 2018

Invasive aspergillosis: current and future challenges in diagnosis and therapy

1 reference

https://api.crossref.org/works/10.1086%2F496927

21 January 2018

Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group

1 reference

https://api.crossref.org/works/10.1086%2F496927

21 January 2018

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1086%2F496927

21 January 2018

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

1 reference

https://api.crossref.org/works/10.1086%2F496927

21 January 2018

Antimicrobial therapy of unexplained fever in neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeits

1 reference

https://api.crossref.org/works/10.1086%2F496927

21 January 2018

Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia

1 reference

https://api.crossref.org/works/10.1086%2F496927

21 January 2018

A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients

1 reference

https://api.crossref.org/works/10.1086%2F496927

21 January 2018

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group

1 reference

https://api.crossref.org/works/10.1086%2F496927

21 January 2018

Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlle

1 reference

https://api.crossref.org/works/10.1086%2F496927

21 January 2018

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

1 reference

https://api.crossref.org/works/10.1086%2F496927

21 January 2018

Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia

1 reference

https://api.crossref.org/works/10.1086%2F496927

21 January 2018

Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation.

1 reference

https://api.crossref.org/works/10.1086%2F496927

21 January 2018

Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study.

1 reference

https://api.crossref.org/works/10.1086%2F496927

21 January 2018

Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1086%2F496927

21 January 2018

Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy

1 reference

https://api.crossref.org/works/10.1086%2F496927

21 January 2018

Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1086%2F496927

21 January 2018

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

1 reference

https://api.crossref.org/works/10.1086%2F496927

21 January 2018

Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1086%2F496927

21 January 2018

The World Health Organization (WHO) classification of the myeloid neoplasms

1 reference

https://api.crossref.org/works/10.1086%2F496927

21 January 2018

Antifungal therapy in patients with fever and neutropenia--more rational and less empirical?

1 reference

https://api.crossref.org/works/10.1086%2F496927

21 January 2018

Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients

1 reference

https://api.crossref.org/works/10.1086%2F496927

21 January 2018

Towards a targeted, risk-based, antifungal strategy in neutropenic patients

1 reference

https://api.crossref.org/works/10.1086%2F496927

21 January 2018

Serial monitoring of Aspergillus antigen in the early diagnosis of invasive aspergillosis. Preliminary investigations with two examples.

1 reference

https://api.crossref.org/works/10.1086%2F496927

21 January 2018

Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia

1 reference

https://api.crossref.org/works/10.1086%2F496927

21 January 2018

False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam.

1 reference

https://api.crossref.org/works/10.1086%2F496927

21 January 2018

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1086%2F496927

21 January 2018

Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi.

1 reference

https://api.crossref.org/works/10.1086%2F496927

21 January 2018

Prospective screening by a panfungal polymerase chain reaction assay in patients at risk for fungal infections: implications for the management of febrile neutropenia

1 reference

https://api.crossref.org/works/10.1086%2F496927

21 January 2018

Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1086%2F496927

21 January 2018

Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1086/422009

Identifiers

1 reference

Europe PubMed Central

21 September 2017

release_3sk4hrqrrje6lnuz5r3cnzkp4a

1 reference

https://api.fatcat.wiki/v0/release/3sk4hrqrrje6lnuz5r3cnzkp4a

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

21 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40497134&oldid=1957690694"